Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features

Samir S. Taneja

doi:10.1016/j.juro.2018.05.115

Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	497-499
Number of pages	3
Journal	The Journal of urology
Volume	200
Issue number	3
DOIs	https://doi.org/10.1016/j.juro.2018.05.115
State	Published - Sep 1 2018

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2018.05.115

Cite this

@article{d7bb334d60d54f0aa2e79f726075e08d,

title = "Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features",

author = "Taneja, {Samir S.}",

year = "2018",

month = sep,

day = "1",

doi = "10.1016/j.juro.2018.05.115",

language = "English (US)",

volume = "200",

pages = "497--499",

journal = "The Journal of urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Re

T2 - Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features

AU - Taneja, Samir S.

PY - 2018/9/1

Y1 - 2018/9/1

UR - http://www.scopus.com/inward/record.url?scp=85056419246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056419246&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2018.05.115

DO - 10.1016/j.juro.2018.05.115

M3 - Comment/debate

C2 - 30412979

AN - SCOPUS:85056419246

SN - 0022-5347

VL - 200

SP - 497

EP - 499

JO - The Journal of urology

JF - The Journal of urology

IS - 3

ER -

Re: Comparison between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer with Adverse Pathological Features

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this